According to the Portugal Business News, Portuguese unicorn Sword Health raises USD 130 million in a mix of primary and secondary sale, increasing the company’s valuation to USD 3 Billion.
Sword Health, the pioneer of AI Health-Care, just announced a financing round of $130 million in a mix of primary and secondary sale to provide liquidity to employees and early investors. This brings the total funding obtained by Sword Health to $ 340 million to date, from major venture capital firms including Khosla Ventures, General Catalyst, Founders Fund, Oxy Capital and Lince Capital.
Sword Health is now valued at $3 billion, that is up 50% from its Series D valuation, and this new funding round comes on the heels of a year in which Sword Health nearly tripled its revenue.
Portuguese company Sword Health, that is now headquartered in New York, is ranked the 26th fastest-growing company in the U.S. on the Inc. 5000 list. Portuguese unicorn Sword Health developed the first AI Care platform that delivers over three million AI sessions to members and is available to over 10,000 employers across three continents.
Sword Health, the pioneer of AI Health-Care, just announced a financing round of $130 million in a mix of primary and secondary sale to provide liquidity to employees and early investors. This brings the total funding obtained by Sword Health to $ 340 million to date, from major venture capital firms including Khosla Ventures, General Catalyst, Founders Fund, Oxy Capital and Lince Capital.
Sword Health is now valued at $3 billion, that is up 50% from its Series D valuation, and this new funding round comes on the heels of a year in which Sword Health nearly tripled its revenue.
Portuguese company Sword Health, that is now headquartered in New York, is ranked the 26th fastest-growing company in the U.S. on the Inc. 5000 list. Portuguese unicorn Sword Health developed the first AI Care platform that delivers over three million AI sessions to members and is available to over 10,000 employers across three continents.
